Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies

Introduction: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Outcome prediction based on early treatment response, along with clinical and laboratory variables, would be very useful for clinical practice. The aim of this study was to deter...

Full description

Saved in:
Bibliographic Details
Main Authors: Charlie W. Lees, J. Jasper Deuring, Michael Chiorean, Marco Daperno, Gianluca Bonfanti, Rebecca Germino, Pritha Bhadra Brown, Irene Modesto, Roger A. Edwards
Format: article
Language:EN
Published: SAGE Publishing 2021
Subjects:
Online Access:https://doaj.org/article/b976d18342f54008bf2cc85a781bf595
Tags: Add Tag
No Tags, Be the first to tag this record!